Exact Mass: 380.10420200000004
Exact Mass Matches: 380.10420200000004
Found 70 metabolites which its exact mass value is equals to given mass value 380.10420200000004,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Meticillin
C17H20N2O6S (380.10420200000004)
Meticillin is only found in individuals that have used or taken this drug. It is one of the penicillins which is resistant to penicillinase but susceptible to a penicillin-binding protein. It is inactivated by gastric acid so administered by injection. [PubChem]Like other beta-lactam antibiotics, meticillin acts by inhibiting the synthesis of bacterial cell walls. It inhibits cross-linkage between the linear peptidoglycan polymer chains that make up a major component of the cell wall of Gram-positive bacteria. It does this by binding to and competitively inhibiting the transpeptidase enzyme used by bacteria to cross-link the peptide (D-alanyl-alanine) used in peptidogylcan synthesis. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CF - Beta-lactamase resistant penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
3,4-diacetoxy-5-(benzoyloxymethyl)-5,6-epoxycyclohexan-1,2-diol
2,3,4-Tri-O-Ac,1-O-benzoyl-alpha-D-Pyranose-Lyxose
2-carbomethoxy-1,4-naphthohydroquinone-4-O-beta-D-glucopyranoside|rubinaphthin A methyl ester
(4S,5R)-4-hydroxy-5-(8-{[3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yl]oxy}octa-2,4,6-triyn-1-yl)dihydrofuran-2(3H)-one|4beta-hydroxy-3,4-dihydrovernoniyne-8-O-beta-glucoside
(4S,5R)-5-(8-hydroxyocta-2,4,6-triyn-1-yl)-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy}dihydrofuran-2(3H)-one|8-hydroxy-3,4-dihydrovernoniyne-4-O-beta-glucoside
Cys Asp Gly Ser
Cys Asp Ser Gly
Cys Gly Asp Ser
Cys Gly Ser Asp
Cys Ser Asp Gly
Cys Ser Gly Asp
Asp Cys Gly Ser
Asp Cys Ser Gly
Asp Gly Cys Ser
Asp Gly Ser Cys
Asp Ser Cys Gly
Asp Ser Gly Cys
Gly Cys Asp Ser
Gly Cys Ser Asp
Gly Asp Cys Ser
Gly Asp Ser Cys
Gly Ser Cys Asp
Gly Ser Asp Cys
Ser Cys Asp Gly
Ser Cys Gly Asp
Ser Asp Cys Gly
Ser Asp Gly Cys
Ser Gly Cys Asp
Ser Gly Asp Cys
(methylcyclopentadienyl)(1,5-cyclooctadiene)iridium(i)
1H-1,4-Diazepine, 1-[(4-chlorophenyl)sulfonyl]-4-(4,6-dimethyl-2-pyrimidinyl)hexahydro- (9CI)
C17H21ClN4O2S (380.10736760000003)
GTS-21
C19H22Cl2N2O2 (380.10582519999997)
GTS-21 dihydrochloride is a selective alpha7 nicotinic acetylcholine receptor (α7-nAChR) agonist with anti?inflammatory and cognition?enhancing activities. GTS-21 dihydrochloride is also a α4β2 (Ki=20 nM for humanα4β2) and 5-HT3A receptor (IC50=3.1 μM) antagonist[1][2].
N-(6-isoquinolin-5-ylnaphthalen-2-yl)thiophene-2-carboxamide
2-benzofuran-1,3-dione,2-ethyl-2-(hydroxymethyl)propane-1,3-diol,furan-2,5-dione
3-[ethyl[4-[(6-nitrobenzothiazol-2-yl)azo]phenyl]amino]propiononitrile
2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydro-3-pyridinecarboxylic acid
C18H21ClN2O5 (380.11389260000004)
bis(ethyl acetoacetato-O1,O3)[propane-1,3-diolato(2-)-O,O]titanium
4-PHENYL-5-(2-PHENYLQUINOLIN-4-YL)-4H-1,2,4-TRIAZOLE-3-THIOL
rubinaphthin A methyl ester
A member of the class of naphthols that is naphthalen-1-ol substituted by a beta-D-glucopyranosyloxy residue at position 4 and a methoxycarbonyl group at position 2. It has been isolated from the roots of Rubia yunnanensis.
5-[2-(2,6-Dioxocyclohexylidene)hydrazinyl]-3-methylthiophene-2,4-dicarboxylic acid diethyl ester
C17H20N2O6S (380.10420200000004)
8-Desmethylnovobiocic acid(1-)
An organic anion obtained by selective deprotonation of the 4-hydroxy group on the chromene ring of 8-desmethylnovobiocic acid.
3-(Benzenesulfonyl)-3-(4-methoxyphenyl)-1-phenyl-1-propanone
C22H20O4S (380.10822400000006)
2-[4-(Difluoromethylthio)anilino]benzoic acid [2-(dimethylamino)-2-oxoethyl] ester
3-[2-(3-Carboxy-acryloylamino)-biphenyl-2-ylcarbamoyl]-acrylic acid
1-(1-Naphthalenyl)-3-[[2-(2-nitrophenoxy)-1-oxoethyl]amino]urea
4-[(2-Cyano-1-oxoethyl)amino]benzoic acid [2-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-oxoethyl] ester
2-[2-methoxy-4-[(E)-2-(8-nitroquinolin-2-yl)ethenyl]phenoxy]acetic acid
sodium 3-aminopropyl 2-acetamido-2-deoxy-alpha-D-glucose-1-phosphate
5,8-Dihydroxy-2-(1-hydroxy-3-methoxy-4-oxocyclohexyl)-3,7-dimethoxychromen-4-one
methicillin
C17H20N2O6S (380.10420200000004)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01C - Beta-lactam antibacterials, penicillins > J01CF - Beta-lactamase resistant penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic A penicillin compound having a (6R)-2,6-dimethoxybenzamido substituent.
IMB-808
IMB-808 is a potent LXRα/β dual agonist with EC50 values of 0.53 μM and 0.15 μM (0.15 μM, using GAL4-pGL4-luc reporter plasmid) for LXRβ and LXRα, respectively. IMB-808 promotes expression of genes related to reverse cholesterol transport (ABCA1 and ABCG1). IMB-808 can be used as a promising agent for the prospective treatment of atherosclerosis research[1].